Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Fine mapping of T-cell immunoglobulin mucin domain gene 1 failed to detect a significant association with multiple sclerosis.

Grabmer C, Nachbauer W, Schanda K, Feurle P, Loacker K, Scholz E, Schennach H, Berger T, Reindl M, Gassner C.

Tissue Antigens. 2010 Mar;75(3):235-41. doi: 10.1111/j.1399-0039.2009.01433.x. Epub 2010 Jan 11.

PMID:
20070602
2.

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.

Gandhi KS, McKay FC, Cox M, Riveros C, Armstrong N, Heard RN, Vucic S, Williams DW, Stankovich J, Brown M, Danoy P, Stewart GJ, Broadley S, Moscato P, Lechner-Scott J, Scott RJ, Booth DR; ANZgene Multiple Sclerosis Genetics Consortium.

Hum Mol Genet. 2010 Jun 1;19(11):2134-43. doi: 10.1093/hmg/ddq090. Epub 2010 Feb 27.

PMID:
20190274
3.

Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis.

Lundmark F, Duvefelt K, Hillert J.

J Neuroimmunol. 2007 Dec;192(1-2):171-3. Epub 2007 Oct 25.

PMID:
17913246
4.

Analysis of IL4R haplotypes in predisposition to multiple sclerosis.

Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA.

Genes Immun. 2004 Mar;5(2):138-41.

PMID:
14712310
5.

Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.

Camiña-Tato M, Morcillo-Suárez C, Navarro A, Fernández M, Horga A, Montalban X, Comabella M.

J Neuroimmunol. 2009 Aug 18;213(1-2):142-7. doi: 10.1016/j.jneuroim.2009.05.010. Epub 2009 Jun 9.

PMID:
19515430
6.

Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.

Teutsch SM, Booth DR, Bennetts BH, Heard RN, Stewart GJ.

J Neuroimmunol. 2004 Mar;148(1-2):218-30.

PMID:
14975605
7.

IL-8 (-251 A/T) and CXCR2 (+1208 C/T) gene polymorphisms and risk of multiple sclerosis in Iranian patients.

Kamali-Sarvestani E, Nikseresht AR, Aliparasti MR, Vessal M.

Neurosci Lett. 2006 Aug 14;404(1-2):159-62. Epub 2006 Jun 21.

PMID:
16793206
8.

Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population.

Heidari M, Behmanesh M, Sahraian MA.

Immunol Invest. 2011;40(3):279-89. doi: 10.3109/08820139.2010.540287. Epub 2010 Dec 29.

PMID:
21190413
9.

Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis.

Camiña-Tato M, Morcillo-Suárez C, Bustamante MF, Ortega I, Navarro A, Muntasell A, López-Botet M, Sánchez A, Carmona P, Julià E, Tortola MT, Audí L, Oksenberg JR, Martin R, Montalban X, Comabella M.

J Immunol. 2010 Nov 1;185(9):5392-404. doi: 10.4049/jimmunol.1000102. Epub 2010 Oct 4. Erratum in: J Immunol. 2011 Aug 1;187(3):1518-21.

10.

Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells.

Hoe E, McKay FC, Schibeci SD, Gandhi K, Heard RN, Stewart GJ, Booth DR.

J Immunol. 2010 Mar 1;184(5):2512-7. doi: 10.4049/jimmunol.0902900. Epub 2010 Jan 22.

11.
12.

Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis.

Scalabrini D, Fenoglio C, Scarpini E, De Riz M, Comi C, Venturelli E, Cortini F, Piola M, Villa C, Naldi P, Monaco F, Bresolin N, Galimberti D.

Neurosci Lett. 2007 Oct 2;425(3):173-6. Epub 2007 Aug 17.

PMID:
17825989
13.

Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.

Galimberti D, Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E, Cortini F, Piola M, Leone M, Dianzani U, D'Alfonso S, Monaco F, Bresolin N, Scarpini E.

J Neurol Sci. 2008 Apr 15;267(1-2):86-90. Epub 2007 Oct 29.

PMID:
17967467
14.

CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis.

Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A.

Acta Neurol Scand. 2009 Dec;120(6):424-9. doi: 10.1111/j.1600-0404.2009.01177.x. Epub 2009 Sep 8.

PMID:
19737153
15.

[Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].

Zhou RM, Li Y, Wang N, Zhang XJ, Dong XJ, Guo W.

Ai Zheng. 2006 Sep;25(9):1113-9. Chinese.

PMID:
16965652
16.

Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.

Perera D, Stankovich J, Butzkueven H, Taylor BV, Foote SJ, Kilpatrick TJ, Rubio JP.

J Neuroimmunol. 2009 Jun 25;211(1-2):105-9. doi: 10.1016/j.jneuroim.2009.03.010. Epub 2009 Apr 17.

PMID:
19375175
17.

The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis.

Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A.

Genes Immun. 2001 Aug;2(5):263-8.

18.

CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.

Stoevring B, Frederiksen JL, Christiansen M.

Clin Chim Acta. 2007 Jan;375(1-2):57-62. Epub 2006 Jun 20.

PMID:
17010329
19.

An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis.

Niino M, Kikuchi S, Fukazawa T, Miyagishi R, Yabe I, Tashiro K.

BMC Neurol. 2002 Aug 21;2:8.

20.

A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Mäurer M, Wiendl H.

Ann Neurol. 2005 Jul;58(1):50-7.

PMID:
15912506

Supplemental Content

Support Center